Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: An individual participant data meta-analysis of 23 studies in the asia-pacific region

Circulation

Volumn 124, Issue 19, 2011, Pages 2056-2064

  Huxley, Rachel R ^a,c   Barzi, Federica ^a   Lam, Tai Hing ^d   Czernichow, Sebastien ^a,e   Fang, Xianghua ^f   Welborn, Tim ^g   Shaw, Jonathan ^h   Ueshima, Hirotsugu ⁱ   Zimmet, Paul ^h   Jee, Sun Ha ^j   Patel, Jeetesh V ^k   Caterson, Ian ^b   Perkovic, Vlado ^a   Woodward, Mark ^a,l  

^a George Institute   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^f CAPITAL MEDICAL UNIVERSITY   (China)

^g SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^h BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

ⁱ SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^j Yonsei University   (South Korea)

^k SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^l JOHNS HOPKINS UNIVERSITY   (United States)

more..

Author keywords

cardiovascular diseases; cholesterol; epidemiology

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; ARTICLE; ASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; STROKE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; AUSTRALASIA; CHOLESTEROL, HDL; CORONARY DISEASE; DYSLIPIDEMIAS; FAR EAST; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS;

EID: 80855152930     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.028373     Document Type: Article

References (34)

1. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-298.
2. Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study. BMJ. 1997;315:722-729. (Pubitemid 27405828)
3. Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsom AR, Sato S, Kiyama M, Nakamura M, Sankai T, Shimamoto T, Komachi Y. Highdensity lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation. 1994;89:2533-2539. (Pubitemid 24173667)
4. Woodward M, Barzi F, Feigin V, Gu D, Huxley R, Nakamura K, Patel A, Ho S, Jamrozik K; Asia Pacific Cohort Studies Collaboration. Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region. Eur Heart J. 2007;28: 2653-2660. (Pubitemid 350071534)
5. Gordon DJ, Probstfield JL. Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8-15. (Pubitemid 19043669)
6. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: a 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol. 1997;17:107-113. (Pubitemid 27057331)
7. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM): results of follow-up at 8 years. Eur Heart J. 1998;19(suppl A):A2-A11. (Pubitemid 28112471)
8. Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol. 1995;75:1189-1195.
9. Burchfiel CM, Laws A, Benfante R, Goldberg RJ, Hwang LJ, Chiu D, Rodriguez BL, Curb JD, Sharp DS. Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation. 1995;92:1430-1436.
10. Rubins HB, Schectman G, Wilt TJ, Iwane MK. Distribution of lipid phenotypes in community-living men with coronary heart disease: high prevalence of isolated low levels of high-density lipoprotein cholesterol. Arch Intern Med. 1992;152:2412-2416.
11. Miller M, Kwiterovich PO Jr. Isolated low HDL cholesterol as an important risk factor for coronary heart disease. Eur Heart J. 1990; 11:9-14.
12. Davidson MH, Rosenson RS. Novel targets that affect high-density lipoprotein metabolism: the next frontier. Am J Cardiol. 2009;104:52E-57E.
13. Woodward M, Barzi F, Martiniuk A, Fang X, Gu DF, Imai Y, Lam TH, Pan WH, Rodgers A, Suh I, Jee SH, Ueshima H, Huxley R; Asia Pacific Cohort Studies Collaboration. APCSC Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol. 2006;35:1412-1416. (Pubitemid 46178914)
14. Zhang X, Patel A, Horibe H, Wu Z, Barzi F, Rodgers A, MacMahon S, Woodward M; Asia Pacific Cohort Studies Collaboration. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol. 2003;32:563-572. (Pubitemid 37039010)
15. Barzi F, Woodward M, Czernichow S, Lee CM, Kang JH, Janus E, Lear S, Patel A, Caterson I, Patel J, Lam TH, Suriyawongpaisal P, Huxley R. The discrimination of dyslipidaemia using anthropometric measures in ethnically diverse populations of the Asia-Pacific Region: the Obesity in Asia Collaboration. Obes Rev. 2010;11:127-136.
16. Huxley R, Barzi F, Stolk R, Caterson I, Gill T, Lam TH, Omari A, Woodward M; Obesity in Asia Collaboration (OAC). Ethnic comparisons of obesity in the Asia-Pacific region: protocol for a collaborative overview of cross-sectional studies. Obes Rev. 2005;6:193-198. (Pubitemid 41032793)
17. Rifai N, Warnick GR, McNamara JR, Belcher JD, Grinstead GF, Frantz ID Jr. Measurement of low-density-lipoprotein cholesterol in serum: a status report. Clin Chem. 1992;38:150-160.
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
19. Bloomgarden ZT. Definitions of the insulin resistance syndrome: the I World Congress on the Insulin Resistance Syndrome. Diabetes Care. 2004;27:824-830. (Pubitemid 38280559)
20. Crouse JR, Byington RP, Furberg CD. HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data. Atherosclerosis. 1998;138:11-24. (Pubitemid 28255150)
21. Tai ES, Emmanuel SC, Chew SK, Tan BY, Tan CE. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes. 1999;48:1088-1092. (Pubitemid 29226356)
22. Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004;97:257-261. (Pubitemid 39286845)
23. Ko M, Kim MT, Nam JJ. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. Int J Cardiol. 2006;110:184-190. (Pubitemid 43767100)
24. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006;105:626-635.
25. Heng D, Ma S, Lee JJ, Tai BC, Mak KH, Hughes K, Chew SK, Chia KS, Tan CE, Tai ES. Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis. 2006;186:367-373. (Pubitemid 44269072)
26. Wild S, McKeigue P. Mortality by country of birth in England and Wales, 1970-1992. BMJ. 1997;314:689-762.
27. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation. 1993;87:152-161. (Pubitemid 23019345)
28. Ghandehari H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidaemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am Heart J. 2008;156: 112-119.
29. Bruckert E, Baccara-Dinet M, Eschwege E. Low HDL-Cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey. Diabet Med. 2007;24: 388-391. (Pubitemid 46452407)
30. Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009; 7:497-514.
31. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb. 1992;12: 911-919.
32. Berglund L, Oliver EH, Fontanez N, Holleran S, Matthews K, Roheim PS, Ginsberg HN, Ramakrishnan R, Lefevre M. HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. Am J Clin Nutr. 1999;70:992-1000.
33. Bruckert E, Labreuche J, Amarenco P. Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. Atherosclerosis. 2010;210:353-361.
34. Bruckert E, Baccara-Dinet M, McCoy F, Chapman J. High prevalence of low HDL-Cholesterol in a pan-European survey of 8545 dyslipidemic patients. Curr Med Res Opin. 2005;21:1927-1934. (Pubitemid 41803102)